125 related articles for article (PubMed ID: 7735161)
1. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-labeled chimeric anti-NCA 95 antigranulocyte monoclonal antibody for bone marrow imaging.
Sarwar M; Higuchi T; Tomiyoshi K; Inoue T; Oriuchi N; Kbalil A; Alyafei S; Sakahara H; Chung JK; Endo K
Radiat Med; 1998; 16(5):391-7. PubMed ID: 9862166
[TBL] [Abstract][Full Text] [Related]
6. Photopenic lesions in bone marrow scintigraphy using technetium-99m labeled antigranulocyte antibody without known tumour.
Krause T; Reinhardt M; Nitzsche E; Moser E
Nuklearmedizin; 1999 Apr; 38(3):85-9. PubMed ID: 10320994
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U
Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
10. Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution. Technical note.
Reske SN; Buell U
Eur J Nucl Med; 1990; 17(1-2):38-41. PubMed ID: 1964640
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
Huić D; Ivancević V; Richter WS; Munz DL
J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow scintigraphy using technetium-99m-antigranulocyte antibody in hematologic disorders.
Chung JK; Yeo J; Lee DS; Park S; Lee MC; Kim BK; Koh CS
J Nucl Med; 1996 Jun; 37(6):978-82. PubMed ID: 8683326
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
15. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
Yao YF; Yang Z; Li ZF; Gu J
World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice.
Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y
Ann Nucl Med; 1994 Feb; 8(1):23-30. PubMed ID: 8204394
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in bone marrow scanning.
Reske SN
Eur J Nucl Med; 1991; 18(3):203-21. PubMed ID: 2040342
[TBL] [Abstract][Full Text] [Related]
19. [Immunoscintigraphy in stomach neoplasms with anti-CEA BW 431/26 monoclonal antibodies marked with Tc 99 m].
González P; Escobar MI; Csendes A; Lillo R; Fodor M; Guzmán G; Baum RP; Massardo T; Gaínza V; Otárola S
Rev Med Chil; 1991 May; 119(5):572-6. PubMed ID: 1844299
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
